Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ONCOGENES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ONCOGENES |
| Key Genes/Proteins | AGING, AKT, AND, APOPTOSIS, App, AUTOPHAGY |
| Related Diseases | Aging, Als, ALS |
| Related Pathways | Akt, Angiogenesis, Apoptosis, Autophagy |
graph TD
ONCOGENES["ONCOGENES"]
style ONCOGENES fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
ONCOGENES -->|"involved_in"| Carcinogenesis["Carcinogenesis"]
ONCOGENES -->|"causes"| Hepatocellular_Carcinoma["Hepatocellular Carcinoma"]
ONCOGENES -->|"interacts"| SWI_SNF([SWI/SNF])
ONCOGENES -->|"activates"| Ms["Ms"]
ONCOGENES -->|"activates"| Als["Als"]
ONCOGENES -->|"activates"| Tumor["Tumor"]
ONCOGENES -->|"activates"| Cancer["Cancer"]
ONCOGENES -->|"activates"| Aging["Aging"]
MET([MET]) -->|"activates"| ONCOGENES
GENES([GENES]) -->|"activates"| ONCOGENES
CANCER([CANCER]) -->|"activates"| ONCOGENES
IGF2BP2([IGF2BP2]) -->|"activates"| ONCOGENES
BRD4([BRD4]) -->|"activates"| ONCOGENES
AGING([AGING]) -->|"activates"| ONCOGENES
RNA([RNA]) -->|"expressed in"| ONCOGENES
OPA1([OPA1]) -->|"activates"| ONCOGENES| Target | Relation | Type | Str |
|---|---|---|---|
| Carcinogenesis | involved_in | process | 0.93 |
| Hepatocellular Carcinoma | causes | disease | 0.85 |
| SWI/SNF | interacts_with | protein | 0.80 |
| Cancer | expressed_in | disease | 0.65 |
| Cancer | causes | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Cirrhosis | activates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Longevity | therapeutic_target | disease | 0.65 |
| Pain | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Carcinoma | causes | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Tumor | causes | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| KLF7 | activates | gene | 0.60 |
| JUN | causes | gene | 0.60 |
| CANCER | causes | gene | 0.60 |
| Cytokine | activates | protein | 0.60 |
| Angiogenesis | activates | pathway | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| CANCER | interacts_with | gene | 0.60 |
| HUB GENES | activates | gene | 0.60 |
| CCL2 | activates | gene | 0.60 |
| Macrophage | activates | cell_type | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| Raf | therapeutic_target | protein | 0.60 |
| Rb | therapeutic_target | protein | 0.60 |
| App | therapeutic_target | protein | 0.60 |
| Raf | activates | protein | 0.60 |
| Igf | activates | protein | 0.60 |
| Ras | activates | protein | 0.60 |
| App | activates | protein | 0.60 |
| BRD4 | activates | gene | 0.60 |
| IGF2BP2 | activates | gene | 0.60 |
| PDGFRA | expressed_in | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HCC | associated_with | disease | 0.70 |
| MET | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| IGF2BP2 | activates | gene | 0.60 |
| BRD4 | activates | gene | 0.60 |
| OPA1 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| CCL2 | activates | gene | 0.60 |
| PDK1 | activates | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| TUMOR SUPPRESSOR GENES | inhibits | gene | 0.60 |
| PROTO-ONCOGENES | inhibits | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| CYP3A4 | activates | gene | 0.60 |
| P53 | activates | gene | 0.60 |
| TUMOR SUPPRESSOR GENES | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| CYP1A2 | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| CEBPB | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| ERCC3 | activates | gene | 0.60 |
| EGF | activates | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| KLF7 | activates | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| AKT | causes | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| SREBP2 | activates | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| DNM1L | activates | gene | 0.60 |
| DRP1 | activates | gene | 0.60 |
| KRAS | activates | gene | 0.60 |
| RAS | associated_with | gene | 0.60 |
| VDAC1 | activates | gene | 0.60 |
| DES | therapeutic_target | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| PDGFRA | expressed_in | gene | 0.60 |
| MYC | causes | gene | 0.60 |
| JUN | causes | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| CANCER | causes | gene | 0.60 |
| HUB GENES | activates | gene | 0.60 |
| MYCN | activates | gene | 0.60 |
| IRF2BP2 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ONCOGENES in their description or question text
No additional research found